Matches in Wikidata for { <http://www.wikidata.org/entity/Q37541753> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- Q37541753 description "article científic" @default.
- Q37541753 description "article scientifique" @default.
- Q37541753 description "articolo scientifico" @default.
- Q37541753 description "artigo científico" @default.
- Q37541753 description "artículu científicu espublizáu en 2014" @default.
- Q37541753 description "bilimsel makale" @default.
- Q37541753 description "scientific article published on 02 January 2014" @default.
- Q37541753 description "vedecký článok" @default.
- Q37541753 description "vetenskaplig artikel" @default.
- Q37541753 description "videnskabelig artikel" @default.
- Q37541753 description "vědecký článek" @default.
- Q37541753 description "wetenschappelijk artikel" @default.
- Q37541753 description "wissenschaftlicher Artikel" @default.
- Q37541753 description "наукова стаття, опублікована в січні 2014" @default.
- Q37541753 description "научни чланак" @default.
- Q37541753 description "مقالة علمية نشرت في 02 يناير 2014" @default.
- Q37541753 name "Use of a population pharmacokinetic approach for the clinical development of a fixed-dose subcutaneous formulation of trastuzumab" @default.
- Q37541753 name "Use of a population pharmacokinetic approach for the clinical development of a fixed-dose subcutaneous formulation of trastuzumab" @default.
- Q37541753 name "Use of a population pharmacokinetic approach for the clinical development of a fixed-dose subcutaneous formulation of trastuzumab" @default.
- Q37541753 type Item @default.
- Q37541753 label "Use of a population pharmacokinetic approach for the clinical development of a fixed-dose subcutaneous formulation of trastuzumab" @default.
- Q37541753 label "Use of a population pharmacokinetic approach for the clinical development of a fixed-dose subcutaneous formulation of trastuzumab" @default.
- Q37541753 label "Use of a population pharmacokinetic approach for the clinical development of a fixed-dose subcutaneous formulation of trastuzumab" @default.
- Q37541753 prefLabel "Use of a population pharmacokinetic approach for the clinical development of a fixed-dose subcutaneous formulation of trastuzumab" @default.
- Q37541753 prefLabel "Use of a population pharmacokinetic approach for the clinical development of a fixed-dose subcutaneous formulation of trastuzumab" @default.
- Q37541753 prefLabel "Use of a population pharmacokinetic approach for the clinical development of a fixed-dose subcutaneous formulation of trastuzumab" @default.
- Q37541753 P1433 Q37541753-0177BC74-A418-42AC-B942-D21769EA8F72 @default.
- Q37541753 P1476 Q37541753-4187BD91-1E46-42EC-B194-2E03D4DFC64F @default.
- Q37541753 P2093 Q37541753-00B6D462-706D-403D-8627-C55DFFAAE2DA @default.
- Q37541753 P2093 Q37541753-4C874926-2262-4573-B0DE-9DD781A026DD @default.
- Q37541753 P2093 Q37541753-53922103-28A5-4FC9-8751-9E47D0EB9AF8 @default.
- Q37541753 P2093 Q37541753-621D22E5-78D7-4372-98EA-6558C54C0DD4 @default.
- Q37541753 P2093 Q37541753-8DF7E99F-F561-49F1-A7F0-99325C478380 @default.
- Q37541753 P2093 Q37541753-C7C31554-F440-4AA6-9755-C7AE31D6F685 @default.
- Q37541753 P2860 Q37541753-01C30B69-2635-4B25-A9C5-1025E5F7AE4F @default.
- Q37541753 P2860 Q37541753-051691A4-895B-43EF-AFE7-41AF8307E702 @default.
- Q37541753 P2860 Q37541753-50F21D89-36EE-4F78-AA01-5664D35BB49C @default.
- Q37541753 P2860 Q37541753-76DE06D2-4498-4099-9271-3CAE558B631E @default.
- Q37541753 P2860 Q37541753-C8D0208D-FEEA-418B-928D-2EDF70C80F83 @default.
- Q37541753 P2860 Q37541753-D49E418C-7C1F-4874-BA8A-635D1B146AA4 @default.
- Q37541753 P2860 Q37541753-DD06501C-3F9F-4985-9066-B4C5CD9BA635 @default.
- Q37541753 P2860 Q37541753-E92B0E51-F341-4968-A8EF-A00048A4EB91 @default.
- Q37541753 P2860 Q37541753-EDAEF0A0-3FDC-465D-A89C-FB64E4641461 @default.
- Q37541753 P2860 Q37541753-EDD3F36C-914E-492D-9DCF-B683636E24D8 @default.
- Q37541753 P2860 Q37541753-F7795DC0-D206-4752-8B65-C9D25287F145 @default.
- Q37541753 P2860 Q37541753-F7FEB81C-0296-43CB-9486-6149A23D5CB5 @default.
- Q37541753 P2860 Q37541753-F95DC14E-AF38-40FC-9869-A057E1C192F8 @default.
- Q37541753 P2860 Q37541753-FFA1617B-9849-4C93-A409-D42ECB707A73 @default.
- Q37541753 P304 Q37541753-BFBC6C4F-6ABF-4A66-AED7-916C5F12D8B3 @default.
- Q37541753 P31 Q37541753-4ABDC341-274D-4632-BA63-E47366164264 @default.
- Q37541753 P356 Q37541753-7F1BB15A-C239-48C5-B6ED-96D8BDC4145A @default.
- Q37541753 P478 Q37541753-6AD12718-F8E8-4292-8752-DD0FA5D94381 @default.
- Q37541753 P577 Q37541753-3E74E258-1055-4E5C-B082-0C3520E051CA @default.
- Q37541753 P5875 Q37541753-56F74EAD-5227-4597-A1A5-A0546E844C64 @default.
- Q37541753 P698 Q37541753-12A94BF1-E8A9-4CD2-AECA-36193B6AB66C @default.
- Q37541753 P921 Q37541753-0DA45157-4DF7-49DB-BC28-8629763E9EE3 @default.
- Q37541753 P932 Q37541753-E1643DD6-F177-4D2F-BD80-3EC4BEB49F83 @default.
- Q37541753 P356 PSP.2013.63 @default.
- Q37541753 P698 25019376 @default.
- Q37541753 P1433 Q27724610 @default.
- Q37541753 P1476 "Use of a population pharmacokinetic approach for the clinical development of a fixed-dose subcutaneous formulation of trastuzumab" @default.
- Q37541753 P2093 "A Lemenuel-Diot" @default.
- Q37541753 P2093 "B Bittner" @default.
- Q37541753 P2093 "B Lum" @default.
- Q37541753 P2093 "C McIntyre" @default.
- Q37541753 P2093 "F Hourcade-Potelleret" @default.
- Q37541753 P2093 "M Brewster" @default.
- Q37541753 P2860 Q28375856 @default.
- Q37541753 P2860 Q29617440 @default.
- Q37541753 P2860 Q37770555 @default.
- Q37541753 P2860 Q37976878 @default.
- Q37541753 P2860 Q38037466 @default.
- Q37541753 P2860 Q46087752 @default.
- Q37541753 P2860 Q46427740 @default.
- Q37541753 P2860 Q48293335 @default.
- Q37541753 P2860 Q57579927 @default.
- Q37541753 P2860 Q59567527 @default.
- Q37541753 P2860 Q59616698 @default.
- Q37541753 P2860 Q64377594 @default.
- Q37541753 P2860 Q80589589 @default.
- Q37541753 P2860 Q81709409 @default.
- Q37541753 P304 "e87" @default.
- Q37541753 P31 Q13442814 @default.
- Q37541753 P356 "10.1038/PSP.2013.63" @default.
- Q37541753 P478 "3" @default.
- Q37541753 P577 "2014-01-02T00:00:00Z" @default.
- Q37541753 P5875 "259705195" @default.
- Q37541753 P698 "25019376" @default.
- Q37541753 P921 Q323936 @default.
- Q37541753 P932 "3910009" @default.